Lukas Burghart

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis': Authors' Reply.

Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis': Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: December 13, 2025

Extending the Baveno VII definition of recompensation to autoimmune hepatitis: Considerations regarding treatment timing and response criteria.

Extending the Baveno VII definition of recompensation to autoimmune hepatitis: Considerations regarding treatment timing and response criteria.

Journal: JHEP reports : innovation in hepatology

Published: August 27, 2025

A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in Vienna.

A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in Vienna.

Journal: Journal of virus eradication

Published: July 18, 2025

Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis.

Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis.

Journal: Alimentary pharmacology & therapeutics

Published: February 10, 2025

Incidence and Clinical Significance of Recompensation After HCV Cure.

Incidence and Clinical Significance of Recompensation After HCV Cure.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 15, 2024

Editorial: Tracking the course of Wilson's disease: Authors' reply.

Editorial: Tracking the course of Wilson's disease: Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: August 09, 2024

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply.

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: May 28, 2024

A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE project.

A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE project.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 27, 2024

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 09, 2024

Portal hypertension and its prognostic implications in patients with Wilson's disease.

Portal hypertension and its prognostic implications in patients with Wilson's disease.

Journal: Alimentary pharmacology & therapeutics

Published: November 21, 2023

Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.

Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.

Journal: Hepatology (Baltimore, Md.)

Published: November 19, 2023

Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.

Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.

Journal: Alimentary pharmacology & therapeutics

Published: November 12, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026